SteadyMed Ltd., with offices in San Ramon, CA and Rehovot, Israel, is a private, venture funded Specialty Pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parenteral delivery needs. These drug products will be approved via the 505(b)(2) regulatory pathway, leading to commercialization by a targeted SteadyMed sales and marketing infrastructure.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/04/14 | $19,600,000 |
KB Partners Samson Ventures | undisclosed |
